Fundamental Analysis of OSCAR HEALTH INC - CLASS A(NYSE:OSCR) stock

Fundamental Rating

Overall OSCR gets a fundamental rating of 2 out of 10. We evaluated OSCR against 141 industry peers in the Insurance industry. OSCR has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, OSCR is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

OSCR had negative earnings in the past year.

In the past year OSCR has reported a negative cash flow from operations.

OSCR had negative earnings in each of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: OSCR reported negative operating cash flow in multiple years.

1.2 Ratios

OSCR has a Return On Assets of -7.52%. This is amonst the worse of the industry: OSCR underperforms 90.71% of its industry peers.

With a Return On Equity value of -33.67%, OSCR is not doing good in the industry: 91.43% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-7.52%
ROE	-33.67%
ROIC	N/A

ROA(3y)-12.72%

ROA(5y)-15.09%

ROE(3y)-47.68%

ROE(5y)-61.63%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

OSCR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OSCR does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OSCR has more shares outstanding

The debt/assets ratio for OSCR is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that OSCR is in the distress zone and has some risk of bankruptcy.

OSCR's Altman-Z score of 1.08 is amongst the best of the industry. OSCR outperforms 82.86% of its industry peers.

A Debt/Equity ratio of 0.37 indicates that OSCR is not too dependend on debt financing.

OSCR's Debt to Equity ratio of 0.37 is in line compared to the rest of the industry. OSCR outperforms 49.29% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.37
Debt/FCF	N/A
Altman-Z	1.08

ROIC/WACCN/A

WACC9.05%

2.3 Liquidity

A Current Ratio of 0.19 indicates that OSCR may have some problems paying its short term obligations.

OSCR's Current ratio of 0.19 is fine compared to the rest of the industry. OSCR outperforms 68.57% of its industry peers.

A Quick Ratio of 0.19 indicates that OSCR may have some problems paying its short term obligations.

OSCR has a Quick ratio of 0.19. This is in the better half of the industry: OSCR outperforms 68.57% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.19
Quick Ratio	0.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

OSCR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.89%, which is quite impressive.

OSCR shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.92%.

The Revenue has been growing by 133.12% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)57.89%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q37.14%

Revenue 1Y (TTM)47.92%

Revenue growth 3Y133.12%

Revenue growth 5YN/A

Revenue growth Q2Q43.87%

3.2 Future

OSCR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.44% yearly.

OSCR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.40% yearly.

EPS Next Y86.74%

EPS Next 2Y52.8%

EPS Next 3Y43.11%

EPS Next 5Y29.44%

Revenue Next Year42.16%

Revenue Next 2Y28.22%

Revenue Next 3Y24.45%

Revenue Next 5Y8.4%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OSCR. In the last year negative earnings were reported.

Also next year OSCR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as OSCR's earnings are expected to grow with 43.11% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y52.8%

EPS Next 3Y43.11%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

OSCR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OSCAR HEALTH INC - CLASS A

NYSE:OSCR (5/1/2024, 7:14:40 PM)

After market: 17.55 +0.19 (+1.09%)

17.36

-0.01 (-0.06%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap3.99B

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.52%
ROE	-33.67%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover1.63

Health

		Industry Rank	Sector Rank
Debt/Equity	0.37
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.19
Quick Ratio	0.19
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)57.89%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y86.74%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)47.92%

Revenue growth 3Y133.12%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

OSCAR HEALTH INC - CLASS A (OSCR)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens